Company / Operating Income
Pasithea Therapeutics Corp. Operating Income History
FY2021-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$4.5M
FY2022
5-year range
-$4.5M / -$41.0K
FY2021-FY2022
Trend
-10898.0%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
-$5M in FY2022.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, operating income decreased 10898.0% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.26 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | -$4.5M | -10898.0% |
| FY2021 | -$41.0K | - |
As of FY2022 · SEC 10-K · Updated Jun 28, 2026